EPSRC logo

Details of Grant 

EPSRC Reference: EP/V055410/1
Title: Volatile organic compound sensing in healthcare using optical interrogation of metal-organic frameworks
Principal Investigator: Korposh, Professor S
Other Investigators:
Morgan, Professor SP Tokay, Dr B Hardman, Professor JG
Laybourn, Dr A
Researcher Co-Investigators:
Project Partners:
Department: Faculty of Engineering
Organisation: University of Nottingham
Scheme: Standard Research
Starts: 01 January 2022 Ends: 28 February 2025 Value (£): 671,743
EPSRC Research Topic Classifications:
Drug Formulation & Delivery Materials Characterisation
Materials Synthesis & Growth
EPSRC Industrial Sector Classifications:
Related Grants:
EP/V056409/1 EP/V055216/1
Panel History:
Panel DatePanel NameOutcome
12 May 2021 Healthcare Technologies Investigator Led Panel May 2021 Announced
Summary on Grant Application Form
Real time detection of certain chemical compounds, referred to as biomarkers, excreted from human body which are related to metabolic processes and chemical composition of drugs in human samples such as breath, blood, urine, sweat and saliva can provide a valuable information about patients' physiological conditions. Volatile organic compounds (VOCs) in the human body have the potential to identify and monitor various diseases such as lung cancer, diabetes and the presence of drugs in the body. The key to precise sensing is to be able to detect a biomarker at low concentrations (high sensitivity) but not be affected by other compounds (high specificity). A metal-organic framework (MOF) is a material current used in applications such as gas storage but has not been extensively exploited in sensing.

This proposal aims to develop a disruptive sensing platform based on measuring optical changes in MOFs and to apply this to challenges in healthcare. To achieve the optimum performance and provide the potential for scale-up and widespread use, it is essential to have a robust manufacturing process. In this application we will develop a new sensor fabrication process based on (i) screening, designing and synthesising the MOF structures to provide the highest sensitivity and selectivity towards the target; (ii) coating an optical fibre using microwave processing to ensure optimum surface coverage and maximum sensitivity; (iii) implementing on a optical fibre configured to provide easy use with high sensitivity.

As an end to end process exemplar, we will implement a sensing platform with high sensitivity and selectivity to rapidly monitor clinically relevant concentrations of the anaesthetic propofol present in the breath. This is important key to improving survival in intensive care is monitoring of the vital physiological parameters such as patient's hemodynamics, temperature, respiratory rate, ventilation, nutrition, and metabolism, as well as the accurate and continuous monitoring of concentration of drugs and biomarkers in blood.

Crucially, the proposed methodology can be extended to other VOCs such as ketones, aldehydes and alcohols that can be used as biomarkers for different diseases, such as lung cancer and diabetes, or indicators of the metabolism of drugs.

Key Findings
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Potential use in non-academic contexts
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Description This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Date Materialised
Sectors submitted by the Researcher
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Project URL:  
Further Information:  
Organisation Website: http://www.nottingham.ac.uk